Sign In
Buy AERI
$15.25
+0 (+0%)
At Close: Feb 17, 2023
Was The Smart Money Right About Aerie Pharmaceuticals Inc (AERI)?
11:15pm, Monday, 11'th May 2020
Hedge funds don't get the respect they used to get. Nowadays investors prefer passive funds over actively managed funds. One thing they don't realize is that 100% of the passive funds didn't see the c
U.S. RESEARCH ROUNDUP-Becton Dickinson, Epam Systems, PayPal Holdings
11:36am, Friday, 08'th May 2020
Wall Street securities analysts on Friday revised their ratings and price targets on several
U.S.-listed companies, including Becton Dickinson, Epam Systems and PayPal Holdings.
HIGHLIGHTS
Aerie Pharmaceuticals, Inc. (AERI) CEO Vicente Anido on Q1 2020 Results - Earnings Call Transcript
04:22am, Friday, 08'th May 2020
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) Q1 2020 Earnings Conference Call May 6, 2020 5:00 P.M. ET Company Participants Ami Bavishi - Director of Investor Rela
Aerie Pharmaceuticals Inc (AERI) Q1 2020 Earnings Call Transcript
10:30pm, Thursday, 07'th May 2020
AERI earnings call for the period ending March 31, 2020.
Edited Transcript of AERI earnings conference call or presentation 6-May-20 9:00pm GMT
08:11pm, Thursday, 07'th May 2020
Q1 2020 Aerie Pharmaceuticals Inc Earnings Call
Mizuho Maintains Buy on Aerie Pharmaceuticals, Lowers Price Target to $29
03:35pm, Thursday, 07'th May 2020SunTrust Robinson Humphrey Maintains Buy on Aerie Pharmaceuticals, Lowers Price Target to $22
03:24pm, Thursday, 07'th May 2020U.S. RESEARCH ROUNDUP-Ashland Global, Lyft, Solaredge Technologies
03:19pm, Thursday, 07'th May 2020
Wall Street securities analysts on Thursday revised their ratings and
price targets on several U.S.-listed companies, including Ashland Global Holdings, Lyft and
Solaredge Technologies.
HIGH
HC Wainwright & Co. Maintains Buy on Aerie Pharmaceuticals, Lowers Price Target to $31
11:21am, Thursday, 07'th May 2020Aerie Pharmaceuticals (AERI) Reports Q1 Loss, Lags Revenue Estimates
09:15pm, Wednesday, 06'th May 2020
Aerie (AERI) delivered earnings and revenue surprises of -12.00% and -3.32%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Aerie Pharmaceuticals Q1 EPS $(0.840) Misses $(0.770) Estimate, Sales $20.341M Beat $20.060M Estimate
08:05pm, Wednesday, 06'th May 2020Aerie Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business Update
08:01pm, Wednesday, 06'th May 2020
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients wi
Aerie Pharmaceuticals, Inc. to Host Earnings Call
07:00pm, Wednesday, 06'th May 2020
NEW YORK, NY / ACCESSWIRE / May 6, 2020 / Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) will be discussing their earnings results in their 2020 First Quarter Earnings call to be held on May 6, 2020 at 5:0
The Daily Biotech Pulse: FDA Nod For AstraZeneca, AbbVie-Allergan Deal Clears Antitrust Hurdle
12:00am, Wednesday, 06'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peak
(Biotech Stocks Hitting 52-week Highs May 5)
• Adverum Biotechnologies...
